First Time Loading...

Co-Diagnostics Inc
NASDAQ:CODX

Watchlist Manager
Co-Diagnostics Inc Logo
Co-Diagnostics Inc
NASDAQ:CODX
Watchlist
Price: 1.14 USD
Updated: Apr 25, 2024

Intrinsic Value

CODX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. [ Read More ]

The intrinsic value of one CODX stock under the Base Case scenario is 0.58 USD. Compared to the current market price of 1.14 USD, Co-Diagnostics Inc is Overvalued by 49%.

Key Points:
CODX Intrinsic Value
Base Case
0.58 USD
Overvaluation 49%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Co-Diagnostics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CODX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Co-Diagnostics Inc

Provide an overview of the primary business activities
of Co-Diagnostics Inc.

What unique competitive advantages
does Co-Diagnostics Inc hold over its rivals?

What risks and challenges
does Co-Diagnostics Inc face in the near future?

Has there been any significant insider trading activity
in Co-Diagnostics Inc recently?

Summarize the latest earnings call
of Co-Diagnostics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Co-Diagnostics Inc.

Provide P/S
for Co-Diagnostics Inc.

Provide P/E
for Co-Diagnostics Inc.

Provide P/OCF
for Co-Diagnostics Inc.

Provide P/FCFE
for Co-Diagnostics Inc.

Provide P/B
for Co-Diagnostics Inc.

Provide EV/S
for Co-Diagnostics Inc.

Provide EV/GP
for Co-Diagnostics Inc.

Provide EV/EBITDA
for Co-Diagnostics Inc.

Provide EV/EBIT
for Co-Diagnostics Inc.

Provide EV/OCF
for Co-Diagnostics Inc.

Provide EV/FCFF
for Co-Diagnostics Inc.

Provide EV/IC
for Co-Diagnostics Inc.

Show me price targets
for Co-Diagnostics Inc made by professional analysts.

What are the Revenue projections
for Co-Diagnostics Inc?

How accurate were the past Revenue estimates
for Co-Diagnostics Inc?

What are the Net Income projections
for Co-Diagnostics Inc?

How accurate were the past Net Income estimates
for Co-Diagnostics Inc?

What are the EPS projections
for Co-Diagnostics Inc?

How accurate were the past EPS estimates
for Co-Diagnostics Inc?

What are the EBIT projections
for Co-Diagnostics Inc?

How accurate were the past EBIT estimates
for Co-Diagnostics Inc?

Compare the revenue forecasts
for Co-Diagnostics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Co-Diagnostics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Co-Diagnostics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Co-Diagnostics Inc compared to its peers.

Compare the P/E ratios
of Co-Diagnostics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Co-Diagnostics Inc with its peers.

Analyze the financial leverage
of Co-Diagnostics Inc compared to its main competitors.

Show all profitability ratios
for Co-Diagnostics Inc.

Provide ROE
for Co-Diagnostics Inc.

Provide ROA
for Co-Diagnostics Inc.

Provide ROIC
for Co-Diagnostics Inc.

Provide ROCE
for Co-Diagnostics Inc.

Provide Gross Margin
for Co-Diagnostics Inc.

Provide Operating Margin
for Co-Diagnostics Inc.

Provide Net Margin
for Co-Diagnostics Inc.

Provide FCF Margin
for Co-Diagnostics Inc.

Show all solvency ratios
for Co-Diagnostics Inc.

Provide D/E Ratio
for Co-Diagnostics Inc.

Provide D/A Ratio
for Co-Diagnostics Inc.

Provide Interest Coverage Ratio
for Co-Diagnostics Inc.

Provide Altman Z-Score Ratio
for Co-Diagnostics Inc.

Provide Quick Ratio
for Co-Diagnostics Inc.

Provide Current Ratio
for Co-Diagnostics Inc.

Provide Cash Ratio
for Co-Diagnostics Inc.

What is the historical Revenue growth
over the last 5 years for Co-Diagnostics Inc?

What is the historical Net Income growth
over the last 5 years for Co-Diagnostics Inc?

What is the current Free Cash Flow
of Co-Diagnostics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Co-Diagnostics Inc.

Financials

Balance Sheet Decomposition
Co-Diagnostics Inc

Current Assets 62.1m
Cash & Short-Term Investments 58.5m
Receivables 330.9k
Other Current Assets 3.3m
Non-Current Assets 33.2m
Long-Term Investments 773.4k
PP&E 6m
Intangibles 26.4m
Current Liabilities 5.7m
Accounts Payable 1.5m
Accrued Liabilities 3m
Other Current Liabilities 1.3m
Non-Current Liabilities 3.6m
Other Non-Current Liabilities 3.6m
Efficiency

Earnings Waterfall
Co-Diagnostics Inc

Revenue
6.8m USD
Cost of Revenue
-4.2m USD
Gross Profit
2.6m USD
Operating Expenses
-45.3m USD
Operating Income
-42.7m USD
Other Expenses
7.4m USD
Net Income
-35.3m USD

Free Cash Flow Analysis
Co-Diagnostics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

CODX Profitability Score
Profitability Due Diligence

Co-Diagnostics Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional 3-Year Average ROE
Negative 1-Year Revenue Growth
36/100
Profitability
Score

Co-Diagnostics Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

CODX Solvency Score
Solvency Due Diligence

Co-Diagnostics Inc's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
66/100
Solvency
Score

Co-Diagnostics Inc's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CODX Price Targets Summary
Co-Diagnostics Inc

Wall Street analysts forecast CODX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CODX is 2.55 USD with a low forecast of 2.53 USD and a high forecast of 2.63 USD.

Lowest
Price Target
2.53 USD
121% Upside
Average
Price Target
2.55 USD
124% Upside
Highest
Price Target
2.63 USD
130% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

CODX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

CODX Price
Co-Diagnostics Inc

1M 1M
+2%
6M 6M
+5%
1Y 1Y
-15%
3Y 3Y
-88%
5Y 5Y
+12%
10Y 10Y
-80%
Annual Price Range
1.14
52w Low
1
52w High
1.85
Price Metrics
Average Annual Return 226.35%
Standard Deviation of Annual Returns 513.73%
Max Drawdown -97%
Shares Statistics
Market Capitalization 35.6m USD
Shares Outstanding 31 260 000
Percentage of Shares Shorted 1.63%

CODX Return Decomposition
Main factors of price return

What is price return decomposition?

CODX News

Other Videos

Company Profile

Co-Diagnostics Inc Logo
Co-Diagnostics Inc

Country

United States of America

Industry

Health Care

Market Cap

35.6m USD

Dividend Yield

0%

Description

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 101 full-time employees. The company went IPO on 2017-07-12. The firm is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. The company also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The firm uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

Contact

UTAH
Salt Lake City
4049 S Highland Dr
+18012789769.0
http://codiagnostics.com/

IPO

2017-07-12

Employees

101

Officers

Chairman & CEO
Mr. Dwight H. Egan
CFO & Company Secretary
Mr. Brian L. Brown CPA
President
Mr. Richard David Abbott
Co-Founder & Member of Scientific Advisory Board
Dr. Brent C. Satterfield Ph.D.
Vice President of Finance & Accounting
Mr. Dan Bohrer CPA
Chief Scientific Officer
Dr. Mark Poritz Ph.D.
Show More
Head of Investor Relations
Mr. Andrew Benson
Senior Vice President of Overseas Operations & Strategic Alliances
Dr. Mayuranki Almaula
Head of Commercialization LATAM/EUR
Mr. Cameron Gundry
Chief Regulatory Affairs Officer
Ms. Ivory Chang
Show Less

See Also

Discover More
What is the Intrinsic Value of one CODX stock?

The intrinsic value of one CODX stock under the Base Case scenario is 0.58 USD.

Is CODX stock undervalued or overvalued?

Compared to the current market price of 1.14 USD, Co-Diagnostics Inc is Overvalued by 49%.